Yorktown Management & Research Company’s MiMedx Group MDXG Stock Holding History

Yorktown Management & Research Company’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-60,926	Closed	-$389K	–	358
2018 Q2	$389K	Buy	60,926 +34,426	+130%	+$245K	0.11%	188
2018 Q1	$185K	Hold	26,500	–	–	0.05%	364
2017 Q4	$334K	Hold	26,500	–	–	0.1%	234
2017 Q3	$315K	Buy	+26,500	New	+$393K	0.08%	226

Other funds holding MDXG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return

Yorktown Management & Research Company's MDXG Position: Q3 2018 in Review

Yorktown Management & Research Company sold out of MiMedx Group (MDXG) in Q3 2018, closing a stake of 60,926 shares — an estimated $389K sold.

Yorktown Management & Research Company first reported a position in MDXG in Q3 2017 and held it in 4 quarters. The position peaked at $389K in Q2 2018. 186 funds tracked by Wall St. Rank hold MDXG as of Q3 2018.

Yorktown Management & Research Company reported no remaining MiMedx Group position as of Q3 2018 after selling out during the quarter.
Yorktown Management & Research Company sold 60,926 MiMedx Group shares in Q3 2018, an estimated $389K.
Yorktown Management & Research Company first reported a position in MiMedx Group in Q3 2017 and held it in 4 quarters.
Yorktown Management & Research Company's MiMedx Group position peaked at $389K in Q2 2018.
186 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2018.

Based on Yorktown Management & Research Company's 13F filing for Q3 2018, filed 8 Nov 2018.